Chronic kidney disease (CKD) is one of the most prevalent and most serious conditions in older companion animals. In cats, prevalence increases significantly with age — affecting approximately 20–50% of cats over 10 years and up to 80% in geriatric cat populations. CKD is the leading cause of death in geriatric cats. In dogs, the median survival time from diagnosis is 226 days according to a large UK primary care study, with survival significantly associated with IRIS stage at diagnosis. These are sobering statistics — but they come with an important qualification. The earlier CKD is diagnosed and managed, the better the outcome: cats diagnosed at IRIS Stage 2 have a mean survival of 2–3 years in many studies, compared to less than 6 months for Stage 4. Structured follow-up that monitors IRIS stage progression and catches deterioration early is the mechanism that determines which end of these survival ranges a patient lands on.
Why CKD follow-up requires more frequent touchpoints than most chronic conditions
CKD is a progressive, irreversible disease with no cure — but its rate of progression is variable and, to some extent, modifiable. Phosphorus restriction, blood pressure management, treatment of proteinuria, and renal diet compliance all slow progression. Each of these interventions requires both laboratory monitoring to assess effect and owner compliance monitoring to ensure the intervention is actually happening. A follow-up call that asks whether the owner is feeding the prescription renal diet consistently, and whether the cat is accepting it, is clinically as important as the next creatinine result.
The polypharmacy burden of CKD management is also significant. Phosphate binders, antihypertensives, erythropoiesis-stimulating agents, anti-nausea medication, appetite stimulants, and potassium supplements are all commonly prescribed in advanced CKD. Each additional medication adds a compliance layer. Research across chronic disease management consistently shows that adherence declines with polypharmacy — and CKD owners managing 4–6 daily medications in a cat that may be increasingly unwell are particularly at risk of selective compliance (giving the ones they think matter most, skipping others).
The IRIS staging system — which stratifies CKD by creatinine, SDMA, blood pressure, and proteinuria — provides the structural framework for follow-up intervals. IRIS recommends monitoring every 3 months for stable CKD, and more frequently when the disease or treatment is changing.
The CKD follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 2–4 weeks post-diagnosis or treatment change | Owner adapting to management plan, prescription diet accepted, medications being given, any acute deterioration, appetite and hydration | Not eating the renal diet at all; acute worsening of thirst, urination, or vomiting — may indicate decompensation or medication side effects |
| 6–8 weeks | Bloods (creatinine, BUN, phosphorus, potassium, SDMA), blood pressure, urinalysis — assess response to management | Rising creatinine or phosphorus despite dietary management — dose adjustment or additional phosphate binder needed; new or worsening hypertension |
| Every 3 months (stable) | Full monitoring panel, IRIS stage assessment, owner-reported signs (appetite, thirst, weight, energy), medication compliance | Any IRIS stage progression — reassess management plan and increase monitoring frequency; significant weight loss |
| Monthly (late-stage or unstable) | Clinical signs, hydration, appetite, weight, subcutaneous fluid compliance if applicable, quality of life assessment | Rapid weight loss, refractory vomiting, severe lethargy — quality of life assessment and owner conversation about prognosis |
What to ask owners during CKD follow-up
- Is [pet name] eating the prescription renal diet consistently — or has she been refusing it?
- Have you been giving all the medications as prescribed — which ones and how often?
- Has her thirst and urination level changed from last time you assessed it?
- Is she maintaining her weight, or continuing to lose weight?
- How is her energy level and activity — engaging normally, or increasingly withdrawn?
- Is she vomiting at all — and if so, how often?
- Has she been drinking enough — and if she’s on subcutaneous fluids, are you managing those confidently?
- Is her appetite improving, stable, or getting worse?
- Are there any new symptoms — muscle weakness, wobbly walking, unusual behaviour?
- Do you have your 3-month monitoring appointment booked?
Common CKD follow-up mistakes clinics make
Not addressing prescription diet compliance actively. Renal diets are protein-restricted, which many cats (and some dogs) find unpalatable — particularly if introduced abruptly during an acute illness episode. Owners frequently report that the cat won’t eat the diet, switch back to the normal food, and don’t tell the clinic. A follow-up call at 2–4 weeks that specifically asks about diet acceptance, and provides practical guidance on gradual transition strategies, significantly improves long-term compliance.
Monitoring labs without monitoring clinical signs. A creatinine that is stable on the laboratory report is reassuring — but an owner who reports the cat is increasingly lethargic, eating less, and losing weight despite a stable creatinine is describing a deteriorating patient. Owner-reported clinical signs should be elicited at every follow-up touchpoint and treated as seriously as the laboratory data.
Not initiating the quality of life conversation early enough. CKD in cats is a terminal condition with a trajectory that most owners understand intellectually but are emotionally unprepared for. A follow-up call that asks “how do you feel she’s doing in herself — does she still seem happy?” opens the quality of life conversation in a gentle, ongoing way that avoids the crisis version of that conversation later. Clinics that have this conversation proactively through regular follow-up keep clients engaged, prepared, and supported.
How to automate CKD follow-up without adding to your team’s workload
Nidana Loop schedules a 2-week post-diagnosis call and monthly owner-reported sign checks for CKD patients automatically from the discharge note. The monthly calls ask about appetite, weight, energy, thirst, and medication compliance — the owner-side data that complements the quarterly laboratory monitoring. For patients with known late-stage CKD or rapid progression, Loop can be set to weekly check-in frequency. The clinic sees a summary and a flag for any case where the owner reports acute deterioration.
See how Loop handles CKD follow-up calls → Book a 20-minute demo
Related: Hyperthyroidism follow-up in cats · Diabetes mellitus follow-up · Congestive heart failure follow-up